Lyell Immunopharma, Inc. (LYEL)

23.76 +0.83 (+3.62%) USD  |  NASDAQ  |  Jan 16, 16:00
23.86 +0.10 (+0.42%) After-Hours: 20:00
More

Lyell Immunopharma Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade